Cargando…
Adjunctive treatment of brexpiprazole with fluoxetine shows a rapid antidepressant effect in social defeat stress model: Role of BDNF-TrkB signaling
Addition of low doses of the atypical antipsychotic drug brexpiprazole with selective serotonin reuptake inhibitors (SSRIs) could promote antidepressant effect in patients with major depressive disorder although the precise mechanisms underlying the action of the combination are unknown. Combination...
Autores principales: | Ma, Min, Ren, Qian, Yang, Chun, Zhang, Ji-chun, Yao, Wei, Dong, Chao, Ohgi, Yuta, Futamura, Takashi, Hashimoto, Kenji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5171769/ https://www.ncbi.nlm.nih.gov/pubmed/27991542 http://dx.doi.org/10.1038/srep39209 |
Ejemplares similares
-
Antidepressant effects of combination of brexpiprazole and fluoxetine on depression-like behavior and dendritic changes in mice after inflammation
por: Ma, Min, et al.
Publicado: (2016) -
BDNF receptor TrkB as the mediator of the antidepressant drug action
por: Casarotto, Plinio, et al.
Publicado: (2022) -
SKF83959 Produces Antidepressant Effects in a Chronic Social Defeat Stress Model of Depression through BDNF-TrkB Pathway
por: Jiang, Bo, et al.
Publicado: (2015) -
The Responsiveness of TrkB to BDNF and Antidepressant Drugs Is Differentially Regulated during Mouse Development
por: Di Lieto, Antonio, et al.
Publicado: (2012) -
Brain-derived Neurotrophic Factor (BDNF)-TrkB Signaling in Inflammation-related Depression and Potential Therapeutic Targets
por: Zhang, Ji-chun, et al.
Publicado: (2016)